Sprintec and Chronic allograft nephropathy - a phase IV clinical study of FDA data

Summary:

We study 5,287 people who take Sprintec (ethinyl estradiol; norgestimate) or have Chronic allograft nephropathy. No report of Chronic allograft nephropathy is found in people who take Sprintec.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.

What is Chronic Allograft Nephropathy?

Chronic allograft nephropathy (failure of kidney transplant) is found to be associated with 59 drugs and 120 conditions by eHealthMe. Check the latest studies of Chronic allograft nephropathy.

On Apr, 12, 2026

No report is found.

Do you take Sprintec and have Chronic allograft nephropathy?

- Check whether Chronic allograft nephropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sprintec:

Sprintec (4,397 reports)

Chronic allograft nephropathy treatments and more:

Chronic allograft nephropathy (890 reports)

How severe was Chronic allograft nephropathy and when was it recovered:

Chronic allograft nephropathy in Sprintec

Expand to all the drugs that have ingredients of ethinyl estradiol; norgestimate:

Chronic allograft nephropathy and drugs with ingredients of ethinyl estradiol; norgestimate

Browse all side effects of Sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic allograft nephropathy:

Chronic allograft nephropathy

Browse all the conditions that are associated with Chronic allograft nephropathy:

Chronic allograft nephropathy

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate (the active ingredients of Sprintec) and Sprintec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.